New diagnosis of systemic lupus erythematosus after COVID-19 vaccination: A case report and review of literature
Urmi Khanna, Yasmine Oprea, Adnan Mir, Caroline Halverstam
Abstract
Coronavirus disease 2019 (COVID-19) mRNA vaccines are highly effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and provide immunity by stimulating host cells to produce viral spike proteins which eventually lead to protective antibody formation.1 The immediate adverse effects following the administration of these vaccines include myalgia, headache, fatigue, chills, and fever. The commonly reported cutaneous side effects include injection site reactions, morbilliform rashes, and urticaria or hypersensitivity reactions.
Topics & Concepts
MedicinemyalgiaChillsImmunologyDermatologyHydroxychloroquineVaccinationAdverse effectCoronavirusCoronavirus disease 2019 (COVID-19)VirologyDiseaseInternal medicineInfectious disease (medical specialty)Systemic Lupus Erythematosus ResearchPeripheral Neuropathies and DisordersSARS-CoV-2 and COVID-19 Research